Pseudarthrosis Treatment Market: How Is Biologics-Augmented Spinal Fusion Becoming the Fastest-Growing Revision Strategy?
Biologics-augmented spinal fusion for pseudarthrosis — the revision surgical approach utilizing recombinant human bone morphogenetic protein-2 (rhBMP-2), demineralized bone matrix, and autologous cellular therapies to overcome failed spinal union and achieve solid arthrodesis in previously non-united spinal segments — creates the most commercially dynamic market segment, with the...
0 Commentarii 0 Distribuiri 31 Views 0 previzualizare